Blog Archives

Therapeutic targets for pemphigus vulgaris discovered

MedWire News: Researchers have identified the primary target of the autoantibodies found in the serum of patients with the blistering skin disorder pemphigus vulgaris (PV). PV patients develop antibodies against the proteins desmoglein (DSG)1 and 3, which help epidermal cells

Tagged with: , , ,
Posted in Around the Globe, News and Information
JOIN TODAY!
The P/P Registry has been approved by the Western Institutional Review Board (WIRB) and is actively enrolling participants.

ENGLISH VERSION

SPANISH VERSION